Pfizer "regrets offense" over demo photos

9 March 2009

Global pharmaceutical behemoth Pfizer has expressed regret over the  offence caused by an employee who took photographs of Harvard Medical  School student demonstrators. Senator Charles Grassley (Republican,  Iowa), the ranking member of the US Senate's Finance Committee, wrote to  Jeffrey Kindler, Pfizer's chairman and chief executive, about the  incident.

In his letter, Sen Grassley said: "I was greatly disturbed to read an  article in the New York Times documenting an employee of your  organization who was taking cellphone photos of Harvard University  medical students demonstrating against pharmaceutical influence on  campus." The Iowa Senator added that he had complained about a previous  incident in 2008, involving the alleged hiring by a drugmaker of a  private investigator to check out the background of a Food and Drug  Administration official.

Sen Grassley asked for documents concerning the payments made by Pfizer  to Harvard Medical School faculty members from 2007 to the present day,  as well as any documents, including e-mails and photographs, since the  beginning of last year concerning any student protests at Harvard  concerning pharmaceutical influence in medicine.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight